Breadcrumb Home Disease State Resources Biosimilars Biosimilars (3 Results) Legislation & Regulation AMCP Policy & Government Relations Agenda – 2022 and Beyond AMCP webinar that provided an overview of AMCP's long-term strategic federal legislative agenda. 4/7/22 Legislation & Regulation AMCP Supports the Reintroduction of H.R. 965, the CREATES ACT AMCP comments to the U.S. House of Representatives in support of legislation that would increase competition and patient access to biosimilars. 2/25/19 Download PDF Legislation & Regulation AMCP CEO Statement on FDA’s Proposed Guidance That Would Reclassi... Press Release: DA’s Proposed Guidance That Would Reclassify Insulin as a Biologic 12/11/18